Entero Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of targeted, non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its pipeline includes Latiglutenase, Capeserod, Adrulipase, and Niclosamide. The company was founded on January 30, 2014 and is headquartered in Boca Raton, FL.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
2
Frequently Asked Questions
What is Market Cap of Entero Therapeutics Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Entero Therapeutics Inc. market cap is $4.29M.
What is the 52-week high for Entero Therapeutics Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Entero Therapeutics Inc. 52 week high is $2.95 as of September 09, 2025.
What is the 52-week low for Entero Therapeutics Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Entero Therapeutics Inc. 52 week low is $0.84 as of September 09, 2025.
What is Entero Therapeutics Inc. stock price today?
Entero Therapeutics Inc. stock price today is $2.63.
What was Entero Therapeutics Inc. stock price yesterday?
Entero Therapeutics Inc. stock price yesterday was $2.70.
What is the PE ratio of Entero Therapeutics Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Entero Therapeutics Inc.’s P/E ratio is -0.24.
What is the Price-to-Book ratio of Entero Therapeutics Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Entero Therapeutics Inc. P/B ratio is -0.6810.
What is the 50-day moving average of Entero Therapeutics Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Entero Therapeutics Inc. 50-day moving average is $1.65.
How many employess does Entero Therapeutics Inc. has?
